News Sentiment

VX1 sentiment intelligence

Vertex Pharmaceuticals Incorporated news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed
Weighted score 52 Balanced news tone 17 relevant articles
Exchange GER Germany
Sector Healthcare Market context
Industry Biotechnology Read-through group
Latest close 425.60 Week of 10 Jul 2026
Weighted tone 52/100

Balanced news tone

Market reaction Price moving ahead of tone

Price is moving more forcefully than the current news tone suggests.

Primary event Market update

77/100 classification confidence.

Company focus 17

directly relevant articles

Source quality 4

high-authority source matches

Trend context Trend active

-7.2% over one week, +11.3% over four weeks, trend active, and near fair-value range.

Latest direct headline Neutral

Is Vertex Pharmaceuticals Successfully Diversifying Beyond Cystic Fibrosis

Market Reaction

Price moving ahead of tone

59/100 confidence

Price is moving more forcefully than the current news tone suggests.

Primary event Market update 77/100 classification
One-week reaction -7.2% Price reacting lower
Trend fit Trend active 11.3% over four weeks
Fair value 8.5% Near fair-value range

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 4
Neutral 12
Negative 1

Relevance

Why the article matched

Direct first
Direct company coverage 17
Industry context 0
Sector context 0

Sources

Coverage mix

Publishers
Seeking Alpha 3
Market source 3
IndexBox 2
Business Wire 2
Kavout | AI 1
The Motley Fool 1
GuruFocus 1
Investing.com Australia 1

Event Lens

What the news is about

Classified themes
Market update 8
Earnings 4
Deals and strategy 2
Regulatory and legal 1
Guidance 1
Analyst action 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 1-17 of 17